CMS Increases Medicare Payment for High-Throughput Covid-19 Lab Tests
The increased payment rate is intended to expand testing capacity and monitoring for covid-19 in nursing homes and other settings with high-volume testing needs.
Read MorePosted by | Apr 30, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The increased payment rate is intended to expand testing capacity and monitoring for covid-19 in nursing homes and other settings with high-volume testing needs.
Read MorePosted by | Apr 29, 2020 | Cleaners & Disinfectants, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Labwear & Consumables |
The FDA- and EPA-approved surface disinfectant kills dangerous pathogens—including SARS-CoV-2 as well as other viruses, bacteria, and microbes—on contact.
Read MorePosted by | Apr 29, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Swabs |
After patients self-swab to collect their nasal sample, they mail their sample, in an insulated package, to a LabCorp facility for testing.
Read MorePosted by | Apr 29, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Research |
“Bright’s abrupt reassignment raises serious questions whether the Trump administration retaliated against him for advocating for science.”
Read MorePosted by | Apr 29, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The BilliontoOne covid-19 test could potentially allow for more than one million additional tests per day in the United States alone.
Read More